Portrait of Klaira Lerma
Klaira Lerma, MPH
she/her
Clinical Research Manager, Director of Research, Green Inequality Lab
Reproductive and Population Health

Master of Public Health Colorado School of Public Health, University of Colorado Anschutz Medical Campus, Denver, CO

Arey W, Lerma K, Beasley A, Harper L, Moayedi G, White K. A Preview of the Dangerous Future of Abortion Bans - Texas Senate Bill 8. N Engl J Med. 2022 Aug 4;387(5):388-390. doi: 10.1056/NEJMp2207423. Epub 2022 Jun 22. PMID: 35731914.

2022

Arey W, Lerma K, Carpenter E, Moayedi G, Harper L, Beasley A, Ogburn T, White K. Abortion Access and Medically Complex Pregnancies Before and After Texas Senate Bill 8. Obstet Gynecol. 2023 May 1;141(5):995-1003. doi: 10.1097/AOG.0000000000005153. Epub 2023 Apr 5. PMID: 37023461; PMCID: PMC10214013.

2023

Arey W, Lerma K, White K. Self-diagnosing the end of pregnancy after medication abortion. Cult Health Sex. 2024 Mar;26(3):405-420. doi: 10.1080/13691058.2023.2212298. Epub 2023 May 22. PMID: 37211833; PMCID: PMC10663384.

2024

Burke KL, Sierra G, Lerma K, White K. Service delivery at Title X sites in Texas during the COVID-19 pandemic. Perspect Sex Reprod Health. 2022 Dec;54(4):198-207. doi: 10.1363/psrh.12211. Epub 2022 Nov 6. PMID: 36336334.

2022

Cahill EP, Lerma K, Shaw KA, Blumenthal PD. Potential candidate for oral pericoital contraception: evaluating ulipristal acetate plus cyclo-oxygenase-2 inhibitor for ovulation disruption. BMJ Sex Reprod Health. 2022 Jul;48(3):217-221. doi: 10.1136/bmjsrh-2021-201446. Epub 2022 Apr 25. PMID: 35470225.

2022

Danna K, Angel A, Kuznicki J, Lemoine L, Lerma K, Kalamar A. Leveraging the Client-Provider Interaction to Address Contraceptive Discontinuation: A Scoping Review of the Evidence That Links Them. Glob Health Sci Pract. 2021 Dec 21;9(4):948-963. doi: 10.9745/GHSP-D-21-00235. PMID: 34933989; PMCID: PMC8691884.

2021

Flynn AN, Lerma K. Update on medication abortion follow-up options: many sizes to fit all. Curr Opin Obstet Gynecol. 2022 Dec 1;34(6):379-385. doi: 10.1097/GCO.0000000000000822. PMID: 36165044.

2022

Henkel A, Lerma K, Reyes G, Gutow H, Shaw JG, Shaw KA. Lactogenesis and breastfeeding after immediate vs delayed birth-hospitalization insertion of etonogestrel contraceptive implant: a noninferiority trial. Am J Obstet Gynecol. 2023 Jan;228(1):55.e1-55.e9. doi: 10.1016/j.ajog.2022.08.012. Epub 2022 Aug 12. PMID: 35964661.

2023

Lerma K, Arey W, Chatillon A, White K. Reasons for participation in abortion research in restrictive settings. Contraception. 2024 Feb;130:110324. doi: 10.1016/j.contraception.2023.110324. Epub 2023 Nov 4. PMID: 37926363.

2024

Lerma K, Arey W, Strelitz-Block E, Nathan S, White K. Abortion Clients' Perceptions of Alternative Medication Abortion Service Delivery Options in Mississippi. Womens Health Issues. 2024 Mar-Apr;34(2):156-163. doi: 10.1016/j.whi.2023.11.009. Epub 2023 Dec 26. PMID: 38151449.

2024

Lerma K, Blumenthal PD. Interest in advance provision of abortion pills: a national survey of potential users in the USA. BMJ Sex Reprod Health. 2023 Jul;49(3):183-191. doi: 10.1136/bmjsrh-2022-201775. Epub 2023 Mar 7. PMID: 36882325.

2023

Lerma K, Carpenter E, Chatillon A, White K. Publicly Funded Family Planning Organizations' Response to the COVID-19 Pandemic in Texas. Womens Health Issues. 2023 May-Jun;33(3):228-234. doi: 10.1016/j.whi.2022.11.003. Epub 2022 Nov 16. PMID: 36535886; PMCID: PMC9666371.

2023

Lerma K, Coplon L, Goyal V. Travel for abortion care: implications for clinical practice. Curr Opin Obstet Gynecol. 2023 Dec 1;35(6):476-483. doi: 10.1097/GCO.0000000000000915. Epub 2023 Sep 12. PMID: 37916900.

2024

Lerma K, Goldthwaite LM, Blumenthal PD, Shaw KA. Transcutaneous Electrical Nerve Stimulation for Pain Management of Aspiration Abortion up to 83 Days of Gestation: A Randomized Controlled Trial. Obstet Gynecol. 2021 Sep 1;138(3):417-425. doi: 10.1097/AOG.0000000000004502. PMID: 34352845.

2021

Lerma K, McBrayer A, Nathan S, Dehlendorf C, White K. Use of a contraceptive decision support tool in the abortion care setting. Contraception. 2022 Sep;113:68-70. doi: 10.1016/j.contraception.2022.01.011. Epub 2022 Jan 23. PMID: 35081390.

2022

Nagle A, Lerma K, White K. Abortion-client religious identity and self-judgment in a setting with antiabortion protestors in Mississippi. Contraception. 2023 May;121:109977. doi: 10.1016/j.contraception.2023.109977. Epub 2023 Feb 8. PMID: 36758738.

2023

Peterson SF, Lerma K, Shaw KA, Blumenthal PD. Cervical Preparation Using Ulipristal Acetate With Adjunct Misoprostol in Second-Trimester Surgical Abortions. Obstet Gynecol. 2022 May 1;139(5):907-909. doi: 10.1097/AOG.0000000000004754. Epub 2022 Apr 5. PMID: 35576349.

2022

Schneyer R, Lerma K, Conti J, Shaw K. Dysmenorrhoea as a risk factor for pain with intrauterine device insertion. BMJ Sex Reprod Health. 2022 Jan;48(e1):e31-e37. doi: 10.1136/bmjsrh-2020-200918. Epub 2021 Mar 31. PMID: 33789955.

2022

White K, Sierra G, Lerma K, Beasley A, Hofler LG, Tocce K, Goyal V, Ogburn T, Potter JE, Dickman SL. Association of Texas' 2021 Ban on Abortion in Early Pregnancy With the Number of Facility-Based Abortions in Texas and Surrounding States. JAMA. 2022 Nov 22;328(20):2048-2055. doi: 10.1001/jama.2022.20423. PMID: 36318197; PMCID: PMC9627516.

2022

Reproductive Health Experiences and Access (RHEA) Study

Focus: Reproductive Health

My role: Co-Investigator

The Supreme Court’s decision in Dobbs v. Jackson Women's Health Organization, or Dobbs, overturned the constitutional right to abortion in 2022. The effects of this decision are likely far-reaching, but we don’t yet have the evidence to fully understand Dobbs’ impacts.

Our research, which includes a survey of more than 45,000 people and focus groups with directly affected people, will fill this knowledge gap.

The Urban Institute, SisterSong Women of Color Reproductive Justice Collective, and the University of Wisconsin–Madison are working together to rigorously assess how Dobbs has affected the broader reproductive health access and experiences, health outcomes, and social and economic well-being of women and other people who can get pregnant—especially for those from marginalized communities, who are likely disproportionately affected.

Black People's Pregnancy Preferences Study (BoPPS)

Focus: Reproductive Health

My role: Co-Investigator

The goal of this research is to investigate how reproductive-aged Black people value abortion method (medication vs. procedure) relative to other care attributes and to identify the structural and legal barriers that can shape those preferences. Medication abortion use has increased substantially in the two decades since the US Food and Drug Administration approved the use of mifepristone, now accounting for over half of US abortions. This proportion will likely grow, given COVID-related changes in medical care provision and the 2021 changes to the mifepristone Risk Evaluation and Mitigation Strategy, which now allows for remote dispensing of the medication. Further, many experts predict that the Supreme Court decision in Dobbs v. Jackson Women’s Health Organization, which dismantled Roe v. Wade and Planned Parenthood v. Casey is likely to increase pregnant people’s reliance on self-managed abortion, including medication abortion.

We will use a mixed-methods design to investigate: 1) abortion method preferences among Black people who can get pregnant and 2) how structural and legal barriers affect these preferences. Our proposed data collection is national in scope but also respondents from the US Midwest; this allows our work to have both national implications and to capture the experience of Midwestern Black people, who experience uniquely high levels of socioeconomic inequality and wide state-level variation in structural and legal barriers to abortion. Only by filling these gaps will we be able to serve the preferences and needs of Black people seeking abortions, whose access to desired care will be more constrained than ever in the post-Dobbs landscape. 

We will use a sequential mixed-methods study design. Specifically, we will first collect qualitative data using individual interviews with abortion facilitators (i.e., abortion providers, clinical support staff, research scholars, abortion doulas, abortion fund and practical support workers) and Black abortion seekers. We will use these qualitative data to inform the care attributes and levels embedded in our survey and discrete choice experiment.

Impacts of Birth Cost Recovery on Black Families in Wisconsin

Focus: Reproductive Justice

Sponsors: Wisconsin Partnership Program (WPP)

My role: Co-Investigator

Birth Cost Recovery (BCR) is a policy that holds some unmarried, non-custodial fathers responsible for Medicaid costs at the time of delivery. Wisconsin is the top enforcer of BCR in the United States, having collected $106 million between 2011 and 2015. Importantly, BCR disproportionately affects Black families, who are more likely than non-Black families to access prenatal BadgerCare and also experience among the worst pregnancy-related outcomes. While supporters of BCR argue that this policy promotes paternal responsibility, others contend that BCR causes financial strain, decreases paternal involvement, and leads to delays in prenatal care access. Yet, we have not established how BCR is impacting the health and wellbeing of Wisconsin families, nor centered the perspectives of the Black families disproportionately affected by this policy. On January 1st, 2020, Dane County stopped collecting new BCR funds, providing an important opportunity to evaluate how BCR impacts Black families.

This is a community-engaged pilot study to better understand how BCR affects Black families in Wisconsin. Specifically, we will be talking to Black parents about their experiences with healthcare, child support, and BCR, including the recent BCR changes in Dane County. We will use their perspectives to develop, refine, and test a survey to rigorously study the impacts of BCR. Specifically, we will:

  • Invite Black parents in Wisconsin who have ongoing or past experience with prenatal Medicaid and/or BCR to participate in individual interviews or focus groups.
  • Develop and refine a survey to capture the effects of BCR on Black parents and their families, including mental and physical health and relationships.
  • Pilot test the survey and compare outcomes between Black Milwaukee families at risk of experiencing BCR and Dane County parents who are not at risk.
Edit profile